Are Your GSA Schedule Products TAA-Compliant?
Client Alert | less than 1 min read | 10.08.14
While Multiple Award Schedules administered by GSA can be a valuable tool for selling to government customers, these government-wide contracts include numerous special requirements, including the requirement that each and every product offered comply with the Trade Agreements Act restriction on providing products from so-called "non-designated countries." In "Where Are Your Products From? The Importance and Challenges of Managing TAA Compliance for GSA Schedule Holders", published in Bloomberg BNA Federal Contracts Report, C&M's Cathy Kunz and Addie Cliffe discuss recent enforcement actions that highlight the risk of TAA non-compliance and offer practical pointers for assuring compliance.
Contacts
Insights
Client Alert | 5 min read | 05.12.26
EU Pharma Package: Advertising Compromise Proposal
In our ninth alert in this EU Pharma Package Series, we discussed the proposals of the Commission, Council, and Parliament with respect to advertising of medicinal products.
Client Alert | 6 min read | 05.11.26
FDA’s AI in Early Phase Clinical Trials RFI: An Opportunity to Help Set the Rules of the Road
Client Alert | 4 min read | 05.11.26
New Temporary State Aid Framework Throws A Lifeline To Sectors Hit By The Middle East Crisis
Client Alert | 4 min read | 05.11.26

